SEC INSIDER TRANSACTIONS

BIO-TECHNE Corp (TECH) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TECH · BIO-TECHNE Corp

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 32 filings · fetched 2026-11-13T20:19:21Z

Recent reported activity

0purchase rows on this page

0sale rows on this page

115matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F2, F3	D Other reported codePerformance Restricted Stock Units · Derivative	698D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F1	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	22,545D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	2,019D	72.4	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	6,547A	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F2, F5	M Exercise / conversionRestricted Stock Units · Derivative	4,903D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F2, F4	M Exercise / conversionRestricted Stock Units · Derivative	4,010D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F2, F3	D Other reported codePerformance Restricted Stock Units · Derivative	12,798D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F2, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	1,067D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F1	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	34,443D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	4,423D	72.4	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	9,980A	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F14	M Exercise / conversionRestricted Stock Units · Derivative	11,785D	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F11	M Exercise / conversionRestricted Stock Units · Derivative	8,543D	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F8	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	24,324D	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F7	D Other reported codePerformance Restricted Stock Units · Derivative	8,835D	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F7	M Exercise / conversionPerformance Restricted Stock Units · Derivative	588D	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F4	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	22,389D	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F3	D Other reported codePerformance Restricted Stock Units · Derivative	8,319D	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	554D	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	10,821D	72.4	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. F6 Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027. F7 On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited. F8 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited. F9 Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028. F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F12 Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028. F13 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F14 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. F15 Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	21,470A	0	Direct	Form 4 ↗0000914190-26-000122
2026-08-15Filed 2026-08-18	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F11	M Exercise / conversionRestricted Stock Units · Derivative	4,903D	0	Direct	Form 4 ↗0000914190-26-000121
2026-08-15Filed 2026-08-18	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F7	M Exercise / conversionRestricted Stock Units · Derivative	4,010D	0	Direct	Form 4 ↗0000914190-26-000121
2026-08-15Filed 2026-08-18	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F4	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	34,982D	0	Direct	Form 4 ↗0000914190-26-000121
2026-08-15Filed 2026-08-18	Hippel JamesOfficer · CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Fully exercisable. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 866 performance RSUs. The remainder of the performance RSUs were forfeited. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,332 performance options. The remainder of the performance options were forfeited. F5 Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. F6 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F7 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F8 Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. F9 11,545 restricted stock units vest on 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. F10 Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). F11 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. F12 Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. References: F2, F3	D Other reported codePerformance Restricted Stock Units · Derivative	12,999D	0	Direct	Form 4 ↗0000914190-26-000121

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.